Living-Donor Lung Transplantation for Post–COVID-19 Respiratory Failure

Living-Donor Lung Transplantation for Post–COVID-19 Respiratory Failure

This report describes a case of coronavirus disease 2019 (COVID-19)–associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her r...

Full description

Bibliographic Details
Main Authors: Date, H. (Author), Hamaji, M. (Author), Nagao, M. (Author), Nakajima, D. (Author), Ohsumi, A. (Author), Takamatsu, J. (Author), Tanaka, S. (Author), Yamazaki, K. (Author), Yuasa, I. (Author), Yutaka, Y. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Online Access:View Fulltext in Publisher
Description
Summary:This report describes a case of coronavirus disease 2019 (COVID-19)–associated respiratory failure requiring urgent living-donor lobar lung transplantation (LDLLTx). Severe hypoxia requiring extracorporeal membrane oxygenation (ECMO) developed in a 57-year-old woman with positive viral status. Her respiratory function deteriorated, with almost totally collapsed lungs. All of her other organs functioned well. After 104 days of ECMO support, she underwent urgent LDLLTx using cardiopulmonary bypass. The grafts worked well, and she was weaned from cardiopulmonary bypass after reperfusion. LDLLTx is an option for selected patients with post–COVID-19 end-stage respiratory failure. © 2022 The Society of Thoracic Surgeons
ISBN:00034975 (ISSN)
DOI:10.1016/j.athoracsur.2021.10.003

Similar Items